Nalaganje...
Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
Of the estimated 5.3 million people with Alzheimer's disease in the United States, more than half would be classified as having moderate or severe disease. Alzheimer's disease is a progressive disorder with the moderate to severe stages generally characterized by significant cognitive, fun...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3042005/ https://ncbi.nlm.nih.gov/pubmed/21299848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-11-21 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|